MyBlueDots

TOKYO–(BUSINESS WIRE)–Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Kazuhiko Fujii) (TOKYO:4118) acquired 96.8% of shares of EndoStream Medical Ltd. (Headquarters: Or Akiva, Israel; CEO: Danel Mayer; hereinafter referred to as ESM), an Israeli medical equipment company, on December 23, 2024. By combining Kaneka’s manufacturing and ESM’s technology, we will jointly develop new medical devices, mainly for cerebrovascular treatment, in addition to the Nautilus™ device for aneury

NEW YORK–(BUSINESS WIRE)–Bonerge announced the initiation of its clinical trial, focusing on Fisetin, Urolithin A, and Ergothioneine. Involving 108 participants, this trial aims to evaluate their combined effects on skin health and organ rejuvenation when taking orally, providing more reliable options for the market. Senolytics Research: Advancing the Science of Anti-Aging In recent years, Senolytics research has advanced rapidly, with institutions like the Mayo Clinic and Wake Forest Univers

GREENBRAE, Calif.–(BUSINESS WIRE)– #Marin–MarinHealth Medical Center (MHMC) announced today that its surgeons have performed the first Aquablation procedures to treat benign prostatic hyperplasia (BPH). MarinHealth is among the few medical centers in the country that have obtained the most advanced version of this AI-enabled, minimally-invasive robotic technology. Aquablation combines high-definition ultrasound imaging and a precise high-pressure water jet controlled by AI-powered robotic technology

SEATTLE–(BUSINESS WIRE)–KitoTech Medical announces the launch of its revolutionary new treatment for pain – PainPause. Designed like a patch making it easy to use yet with the strength to treat serious pain, PainPause contains patented tiny Micro-Points that are able to shut down pain without drugs. PainPause remains in place on the skin for a week providing long-lasting pain relief with a single treatment. PainPause effectively treats a wide range of painful musculoskeletal conditions includ

CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–Aptar Announces 2025 Quarterly Conference Call Dates